These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30949490)

  • 1. Volatile organic compound profiles in outlet air from extracorporeal life-support devices differ from breath profiles in critically ill patients.
    Leopold JH; Philipp A; Bein T; Redel A; Gruber M; Schultz MJ; Abu-Hanna A; Brinkman P; Janssen HG; Bos LDJ
    ERJ Open Res; 2019 Apr; 5(2):. PubMed ID: 30949490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive breath monitoring with eNose does not improve glucose diagnostics in critically ill patients in comparison to continuous glucose monitoring in blood.
    Leopold JH; Bos LDJ; Colombo C; Sterk PJ; Schultz MJ; Abu-Hanna A
    J Breath Res; 2017 Apr; 11(2):026002. PubMed ID: 28260695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma.
    Brinkman P; van de Pol MA; Gerritsen MG; Bos LD; Dekker T; Smids BS; Sinha A; Majoor CJ; Sneeboer MM; Knobel HH; Vink TJ; de Jongh FH; Lutter R; Sterk PJ; Fens N
    Clin Exp Allergy; 2017 Sep; 47(9):1159-1169. PubMed ID: 28626990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation of volatile organic compound levels within ambient room air and its impact upon the standardisation of breath sampling.
    Hewitt MJ; Belluomo I; Zuffa S; Boshier PR; Myridakis A
    Sci Rep; 2022 Sep; 12(1):15887. PubMed ID: 36151300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple breath sampling method in intubated and mechanically ventilated critically ill patients.
    Bos LD; Wang Y; Weda H; Nijsen TM; Janssen AP; Knobel HH; Vink TJ; Schultz MJ; Sterk PJ
    Respir Physiol Neurobiol; 2014 Jan; 191():67-74. PubMed ID: 24239875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study.
    Lamote K; Brinkman P; Vandermeersch L; Vynck M; Sterk PJ; Van Langenhove H; Thas O; Van Cleemput J; Nackaerts K; van Meerbeeck JP
    Oncotarget; 2017 Oct; 8(53):91593-91602. PubMed ID: 29207669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alveolar air volatile organic compound extractor for clinical breath sampling.
    de Silva G; Beyette FR
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():5369-72. PubMed ID: 25571207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting Pulmonary Oxygen Toxicity Using eNose Technology and Associations between Electronic Nose and Gas Chromatography-Mass Spectrometry Data.
    Wingelaar TT; Brinkman P; de Vries R; van Ooij PAM; Hoencamp R; Maitland-van der Zee AH; Hollmann MW; van Hulst RA
    Metabolites; 2019 Nov; 9(12):. PubMed ID: 31766640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient air.
    Delfino RJ; Gong H; Linn WS; Hu Y; Pellizzari ED
    J Expo Anal Environ Epidemiol; 2003 Sep; 13(5):348-63. PubMed ID: 12973363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis by Volatile Organic Compounds in Exhaled Breath from Lung Cancer Patients Using Support Vector Machine Algorithm.
    Sakumura Y; Koyama Y; Tokutake H; Hida T; Sato K; Itoh T; Akamatsu T; Shin W
    Sensors (Basel); 2017 Feb; 17(2):. PubMed ID: 28165388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
    Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
    Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of different approaches for exhaled breath and tumor tissue analyses to identify lung cancer biomarkers.
    Gashimova E; Temerdashev A; Porkhanov V; Polyakov I; Perunov D; Azaryan A; Dmitrieva E
    Heliyon; 2020 Jun; 6(6):e04224. PubMed ID: 32577579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia.
    Schnabel R; Fijten R; Smolinska A; Dallinga J; Boumans ML; Stobberingh E; Boots A; Roekaerts P; Bergmans D; van Schooten FJ
    Sci Rep; 2015 Nov; 5():17179. PubMed ID: 26608483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
    Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
    Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaled Breath and Oxygenator Sweep Gas Propionaldehyde in Acute Respiratory Distress Syndrome.
    Meidert AS; Choukèr A; Praun S; Schelling G; Dolch ME
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33396196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
    Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
    J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary Oxygen Toxicity in Navy Divers: A Crossover Study Using Exhaled Breath Analysis After a One-Hour Air or Oxygen Dive at Nine Meters of Sea Water.
    Wingelaar TT; van Ooij PAM; Brinkman P; van Hulst RA
    Front Physiol; 2019; 10():10. PubMed ID: 30740057
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of transportation and storage using sorbent tubes of exhaled breath samples on diagnostic accuracy of electronic nose analysis.
    van der Schee MP; Fens N; Brinkman P; Bos LD; Angelo MD; Nijsen TM; Raabe R; Knobel HH; Vink TJ; Sterk PJ
    J Breath Res; 2013 Mar; 7(1):016002. PubMed ID: 23257711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exhaled Breath Profiles Before, During and After Exacerbation of COPD: A Prospective Follow-Up Study.
    van Velzen P; Brinkman P; Knobel HH; van den Berg JWK; Jonkers RE; Loijmans RJ; Prins JM; Sterk PJ
    COPD; 2019 Dec; 16(5-6):330-337. PubMed ID: 31588813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exhaled volatile organic compounds and lung microbiome in COPD: a pilot randomised controlled trial.
    Mohan D; Keir HR; Richardson H; Mayhew D; Boyer J; van der Schee MP; Allsworth MD; Miller BE; Tal-Singer R; Chalmers JD
    ERJ Open Res; 2021 Oct; 7(4):. PubMed ID: 34616836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.